Literature DB >> 8787431

Long term treatment with betaine in methylenetetrahydrofolate reductase deficiency.

E Ronge1, B Kjellman.   

Abstract

A girl aged 7.5 years with deficiency of 5,10-methylenetetrahydrofolate reductase was treated from early infancy with betaine, 3-6 g daily. She has slight microcephaly, moderate developmental delay, and impaired vision but there have been no obvious signs of folate deficiency. From 4 years of age, she developed an unexplained extreme increase in appetite and weight. Recent magnetic resonance imaging of her brain was normal. The plasma methionine levels have been normal but in the lower range, and the total plasma homocysteine concentrations have been moderately increased (54 to 85 mumol/l) without obvious correlation with the different betaine doses given. Folic acid has sometimes been added.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8787431      PMCID: PMC1511422          DOI: 10.1136/adc.74.3.239

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity.

Authors:  S H Mudd; B W Uhlendorf; J M Freeman; J D Finkelstein; V E Shih
Journal:  Biochem Biophys Res Commun       Date:  1972-01-31       Impact factor: 3.575

2.  Mannosidosis: a clinical and histopathologic study.

Authors:  B Kjellman; I Gamstorp; A Brun; P A Ockerman; B Palmgren
Journal:  J Pediatr       Date:  1969-09       Impact factor: 4.406

3.  Diencephalic syndromes of infancy. Report of 3 children with emaciation syndrome and disproportionately large hands and feet.

Authors:  I Gamstorp; B Kjellman; B Palmgren
Journal:  J Pediatr       Date:  1967-03       Impact factor: 4.406

4.  Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway.

Authors:  R Surtees; J Leonard; S Austin
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

5.  Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease.

Authors:  L E Brattstrom; J E Hardebo; B L Hultberg
Journal:  Stroke       Date:  1984 Nov-Dec       Impact factor: 7.914

6.  Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency.

Authors:  U Wendel; H J Bremer
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

7.  Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency.

Authors:  E Holme; B Kjellman; E Ronge
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

8.  Association of cerebrospinal fluid deficiency of 5-methyltetrahydrofolate, but not S-adenosylmethionine, with reduced concentrations of the acid metabolites of 5-hydroxytryptamine and dopamine.

Authors:  R Surtees; S Heales; A Bowron
Journal:  Clin Sci (Lond)       Date:  1994-06       Impact factor: 6.124

  8 in total
  3 in total

Review 1.  The Pediatric Methionine Requirement Should Incorporate Remethylation Potential and Transmethylation Demands.

Authors:  Jason L Robinson; Robert F Bertolo
Journal:  Adv Nutr       Date:  2016-05-16       Impact factor: 8.701

2.  Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency.

Authors:  Martina Huemer; Regina Mulder-Bleile; Patricie Burda; D Sean Froese; Terttu Suormala; Bruria Ben Zeev; Patrick F Chinnery; Carlo Dionisi-Vici; Dries Dobbelaere; Gülden Gökcay; Mübeccel Demirkol; Johannes Häberle; Alexander Lossos; Eugen Mengel; Andrew A Morris; Klary E Niezen-Koning; Barbara Plecko; Rossella Parini; Dariusz Rokicki; Manuel Schiff; Mareike Schimmel; Adrian C Sewell; Wolfgang Sperl; Ute Spiekerkoetter; Beat Steinmann; Grazia Taddeucci; Jose M Trejo-Gabriel-Galán; Friedrich Trefz; Megumi Tsuji; María Antònia Vilaseca; Jürgen-Christoph von Kleist-Retzow; Valerie Walker; Jiri Zeman; Matthias R Baumgartner; Brian Fowler
Journal:  J Inherit Metab Dis       Date:  2015-05-30       Impact factor: 4.982

Review 3.  Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.

Authors:  Martina Huemer; Daria Diodato; Bernd Schwahn; Manuel Schiff; Anabela Bandeira; Jean-Francois Benoist; Alberto Burlina; Roberto Cerone; Maria L Couce; Angeles Garcia-Cazorla; Giancarlo la Marca; Elisabetta Pasquini; Laura Vilarinho; James D Weisfeld-Adams; Viktor Kožich; Henk Blom; Matthias R Baumgartner; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2016-11-30       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.